Tacrolimus ointment 0.03% in the eye for treatment of giant papillary conjunctivitis

Cornea

Volumn 27, Issue 2, 2008, Pages 228-229

  Kymionis, George D ^a,b   Goldman, David ^a   Ide, Takeshi ^a   Yoo, Sonia H ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Giant papillary conjunctivitis; Refractory; Tacrolimus 0.03

Indexed keywords

ANTIHISTAMINIC AGENT; CORTICOSTEROID; TACROLIMUS;

ADOLESCENT; ARTICLE; BLEPHAROSPASM; BURNING SENSATION; CASE REPORT; DRUG DOSE REDUCTION; EYE; EYE DISCHARGE; GIANT PAPILLARY CONJUNCTIVITIS; HUMAN; MALE; OCULAR PRURITUS; PHOTOPHOBIA; PRIORITY JOURNAL; SURGICAL TECHNIQUE;

ADMINISTRATION, TOPICAL; ADOLESCENT; CONJUNCTIVITIS, ALLERGIC; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; OINTMENTS; TACROLIMUS; TREATMENT OUTCOME;

EID: 38549121741     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICO.0b013e318159afbb     Document Type: Article

References (7)

1. Leonardi A. Vernal keratoconjunctivitis: pathogenesis and treatment. Prog Retin Eye Res. 2002;21:319-339.
2. Kang S, Lucky AW, Pariser D, et al. Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children. J Am Acad Dermatol. 2001;44:S58-S64.
3. Paller A, Eichenfield LF, Leung DY, et al. A 12-week study of tacrolimus ointment for the treatment of atopic dermatitis in pediatric patients. J Am Acad Dermatol. 2001;44:S47-S57.
4. Rikkers SM, Holland GN, Drayton GE. Topical tacrolimus treatment of atopic eyelid disease. Am J Ophthalmol. 2003;135:297-302.
5. Kymionis GD, Tsilimbaris M, Iliaki O, et al. Treatment of atopic eyelid disease using topical tacrolimus following corticosteroid discontinuation in a patient with open-angle glaucoma. Cornea. 2004;23:828-830.
6. Joseph MA, Kaufman HE, Insler M. Topical tacrolimus ointment for treatment of refractory anterior segment inflammatory disorders. Cornea. 2005;24:417-420.
7. Vichvanond P, Tantimongkolsuk C, Dumrongkigchairporn P, et al. Vernal keratoconjuctivitis: results of a novel therapy with 0.1% topical ophthalmic FK-506 ointment. J Allergy Clin Immunol. 2004;113:355-358.